BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33422739)

  • 1. Chromoblastomycosis by Exophiala jeanselmei associated with squamous cell carcinoma.
    Wang J; Zhu M; Wang P
    J Mycol Med; 2021 Mar; 31(1):101105. PubMed ID: 33422739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.
    Rojas OC; González GM; Moreno-Treviño M; Salas-Alanis J
    Mycopathologia; 2015 Feb; 179(1-2):153-7. PubMed ID: 25344197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoblastomycosis: A Rare Presentation With Polymorphic Cutaneous Lesions And Bone Involvement, Caused By Exophiala Janselmei.
    Rehman BU; Mansoor M; Talat H; Mirza R; Ishfaq F
    J Ayub Med Coll Abbottabad; 2023; 35(3):503-506. PubMed ID: 38404104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromoblastomycosis in a Diabetic Patient Without a History of Trauma.
    Zarei M; Schneider S; Villasante A; Villada G; Patel T; Hu S; Romanelli P
    Am J Dermatopathol; 2015 Sep; 37(9):e112-5. PubMed ID: 25830721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyphellophora laciniata: A new etiological agent of chromoblastomycosis.
    León-Lara X; Atoche C; Arenas R; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Vázquez-Aceituno VA; Hernández-Castro R
    J Mycol Med; 2022 Mar; 32(1):101204. PubMed ID: 34598111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: Disseminated chromoblastomycosis caused by phialophora.
    Qiu Y; Zhang J; Tang Y; Zhong X; Deng J
    J Infect Chemother; 2019 Dec; 25(12):1031-1036. PubMed ID: 31229375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic disfiguring facial lesions in an immunocompetent patient due to Exophiala spinifera: a case report and review of literature.
    Singh G; Shivaprakash MR; De D; Gupta P; Gupta S; Kanwar AJ; Chakrabarti A
    Mycopathologia; 2012 Oct; 174(4):293-9. PubMed ID: 22660887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoblastomycosis in a patient with a cardiac transplant.
    Kinkead S; Jancic V; Stasko T; Boyd AS
    Cutis; 1996 Nov; 58(5):367-70. PubMed ID: 8934080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromoblastomycosis caused by Exophiala spinifera.
    Padhye AA; Hampton AA; Hampton MT; Hutton NW; Prevost-Smith E; Davis MS
    Clin Infect Dis; 1996 Feb; 22(2):331-5. PubMed ID: 8838192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei.
    Padhye AA; Ajello L
    Mykosen; 1987 Mar; 30(3):134. PubMed ID: 3587275
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanized fungal infections in kidney transplant recipients: contributions to optimize clinical management.
    Santos DW; Camargo LF; Gonçalves SS; Ogawa MM; Tomimori J; Enokihara MM; Medina-Pestana JO; Colombo AL
    Clin Microbiol Infect; 2017 May; 23(5):333.e9-333.e14. PubMed ID: 28062320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species.
    Badali H; Najafzadeh MJ; van Esbroeck M; van den Enden E; Tarazooie B; Meis JF; de Hoog GS
    Med Mycol; 2010 Mar; 48(2):318-27. PubMed ID: 19642051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromoblastomycosis. First allochthonous case treated in Chile].
    Jahr C; Peruilh L; Jiménez M; Bobadilla F; Segovia L
    Rev Chilena Infectol; 2022 Jun; 39(3):349-353. PubMed ID: 36156698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei.
    Naka W; Harada T; Nishikawa T; Fukushiro R
    Mykosen; 1986 Oct; 29(10):445-52. PubMed ID: 3540662
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromoblastomycosis.
    Queiroz-Telles F; de Hoog S; Santos DW; Salgado CG; Vicente VA; Bonifaz A; Roilides E; Xi L; Azevedo CM; da Silva MB; Pana ZD; Colombo AL; Walsh TJ
    Clin Microbiol Rev; 2017 Jan; 30(1):233-276. PubMed ID: 27856522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in collagen disease patient.
    Nomura M; Maeda M; Seishima M
    J Dermatol; 2010 Dec; 37(12):1046-50. PubMed ID: 21083708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangitic chromoblastomycosis.
    Muhammed K; Nandakumar G; Asokan KK; Vimi P
    Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.